During a White House press conference announcing a new deal on weight-loss medications, Novo Nordisk executive Gordon Findlay suddenly collapsed behind President Donald Trump.
His knees gave out unexpectedly, prompting administration officials and pharmaceutical representatives to rush to his aid to prevent him from falling.
White House Press Secretary Karoline Leavitt confirmed the incident took place during the "Most Favored Nations Oval Office Announcement." She stated:
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Medics on site responded promptly, and the individual was reported to be fine afterward.
Press witnesses noted that Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, helped Findlay to the ground, aiming to protect him from head injury.
Following the incident, reporters were asked to leave the Oval Office while cabinet members attended to Findlay and elevated his legs.
The event resumed shortly after, with all parties assuring the executive's condition was stable following the sudden collapse.
Author's summary: A sudden collapse of a pharmaceutical executive during a White House press briefing was quickly managed on site, allowing the event to continue without further disruption.